Dysplasia- means literally- disordered growth- is a general, non-organ specific term used to refer to an abnormal development with a loss of uniformity of the individual cells and loss in architectural orientation. Dysplastic cells are generally an expansion of immature cells with increased pleomorphism, n/c ratio and mitoses. Dysplasia is regarded, generally, as a precancerous growth pattern- ie cervical dysplasia; and typically warrants intervention/ removal.
Atypical hyperplasia is not the same- it is a term mostly reserved for describing abnormal breast ductal epithelium which features breast cells which become abnormal in number, size, shape, growth pattern and appearance- mostly on an architectural scale- but the individual cell features are not frankly dysplastic. The location of the abnormal cells within the breast tissue the lobules or the milk ducts determines whether the cells are atypical lobular hyperplasia (ALH) or atypical ductal hyperplasia (ADH). In practice the distinction between ADH/ALH and dysplasia (DCIS/LCIS) is very vague, subjective and professionally challenging. Although ADH/ALH are not technically "precancerous" it matters because asigning a diagnosis of ADH/ALH portends a 5x increased risk of breast cancer, although ADH/ALH by itself doesnt necessarily need to be "treated".